Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other ...

Learn more about whether The GEO Group, Inc. or MSA Safety Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The di MSA Safety's (NYSE:MSA) stock up by 4.3% over the past three months. We wonder if and what role the company's... Stryve Foods, Nevro, Canoo, MSA Safety and VTEX have been highlighted in ...

Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –– Achieved Statistical Significance with Up to 48% Slowing of Clinical ...

Alterity Therapeutics shares are moving higher on Thursday after the company reported positive topline results from its Phase 2 clinical trial of ATH434 in early-stage multiple system atrophy.

Alterity Therapeutics (ATHE) stock jumps as its lead asset, ATH434, shows promise in slowing clinical progression in multiple ...

MSA opened at $162.87 on Monday. MSA Safety has a fifty-two week low of $153.79 and a fifty-two week high of $200.60. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.56 and a ...

Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy ...

In just the first nine months of 2024, though, the company had sold 2,200 AMRs, powered by the launch of its newest product, the X4 ROVR. Thanks to this acceleration in growth, AMR equipment now ...

bioMUSE Natural History Study The Company’s “Biomarkers of progression in Multiple System Atrophy” (bioMUSE) natural history study has produced promising data to track the progression of individuals ...